110 related articles for article (PubMed ID: 18450608)
1. Diagnosis and prognosis in acute myeloid leukemia--the art of distinction.
Löwenberg B
N Engl J Med; 2008 May; 358(18):1960-2. PubMed ID: 18450608
[No Abstract] [Full Text] [Related]
2. Prognostic significance of CEBPA mutations in a large cohort of younger adult patients with acute myeloid leukemia: impact of double CEBPA mutations and the interaction with FLT3 and NPM1 mutations.
Green CL; Koo KK; Hills RK; Burnett AK; Linch DC; Gale RE
J Clin Oncol; 2010 Jun; 28(16):2739-47. PubMed ID: 20439648
[TBL] [Abstract][Full Text] [Related]
3. [Comprehensive analysis of gene abnormalities in acute myeloid leukemia according to the WHO classification].
Ishikawa Y
Rinsho Ketsueki; 2009 Aug; 50(8):597-603. PubMed ID: 19915373
[No Abstract] [Full Text] [Related]
4. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
Schlenk RF; Döhner K; Krauter J; Fröhling S; Corbacioglu A; Bullinger L; Habdank M; Späth D; Morgan M; Benner A; Schlegelberger B; Heil G; Ganser A; Döhner H;
N Engl J Med; 2008 May; 358(18):1909-18. PubMed ID: 18450602
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of acute myeloid leukemia.
Döhner K; Döhner H
Haematologica; 2008 Jul; 93(7):976-82. PubMed ID: 18591623
[No Abstract] [Full Text] [Related]
6. Molecular genetics of adult acute myeloid leukemia: prognostic and therapeutic implications.
Marcucci G; Haferlach T; Döhner H
J Clin Oncol; 2011 Feb; 29(5):475-86. PubMed ID: 21220609
[TBL] [Abstract][Full Text] [Related]
7. [Acute myeloid leukemia].
Watanabe R
Rinsho Ketsueki; 2009 Mar; 50(3):154-9. PubMed ID: 19352081
[No Abstract] [Full Text] [Related]
8. Differential expression of specific microRNA and their targets in acute myeloid leukemia.
Cammarata G; Augugliaro L; Salemi D; Agueli C; La Rosa M; Dagnino L; Civiletto G; Messana F; Marfia A; Bica MG; Cascio L; Floridia PM; Mineo AM; Russo M; Fabbiano F; Santoro A
Am J Hematol; 2010 May; 85(5):331-9. PubMed ID: 20425795
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in AML in relation to (ab)normal karyotype.
Stone RM
Best Pract Res Clin Haematol; 2009 Dec; 22(4):523-8. PubMed ID: 19959103
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression in cytogenetically normal acute myeloid leukemia.
Marcucci G; Radmacher MD; Maharry K; Mrózek K; Ruppert AS; Paschka P; Vukosavljevic T; Whitman SP; Baldus CD; Langer C; Liu CG; Carroll AJ; Powell BL; Garzon R; Croce CM; Kolitz JE; Caligiuri MA; Larson RA; Bloomfield CD
N Engl J Med; 2008 May; 358(18):1919-28. PubMed ID: 18450603
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of cooperative gene mutations between class I and class II in de novo acute myeloid leukemia.
Ishikawa Y; Kiyoi H; Tsujimura A; Miyawaki S; Miyazaki Y; Kuriyama K; Tomonaga M; Naoe T
Eur J Haematol; 2009 Aug; 83(2):90-8. PubMed ID: 19309322
[TBL] [Abstract][Full Text] [Related]
12. Cup-like acute myeloid leukemia: new disease or artificial phenomenon?
Kroschinsky FP; Schäkel U; Fischer R; Mohr B; Oelschlaegel U; Repp R; Schaich M; Soucek S; Baretton G; Ehninger G; Thiede C;
Haematologica; 2008 Feb; 93(2):283-6. PubMed ID: 18223289
[TBL] [Abstract][Full Text] [Related]
13. Comparing apples and oranges in normal karyotype acute myeloid leukemia.
Medeiros BC
J Clin Oncol; 2009 Jan; 27(3):474; author reply 474-6. PubMed ID: 19075259
[No Abstract] [Full Text] [Related]
14. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
15. Mutated gene markers predict outcome for patients with AML.
McBride D
ONS Connect; 2012 May; 27(5):21. PubMed ID: 22690521
[No Abstract] [Full Text] [Related]
16. Role of nucleophosmin in acute myeloid leukemia.
Meani N; Alcalay M
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors of acute myeloid leukemia].
Inokuchi K
Nihon Rinsho; 2012 Apr; 70 Suppl 2():389-93. PubMed ID: 23133988
[No Abstract] [Full Text] [Related]
18. Analysis of FLT3-ITD and FLT3-Asp835 mutations in de novo acute myeloid leukemia: evaluation of incidence, distribution pattern, correlation with cytogenetics and characterization of internal tandem duplication from Indian population.
Ahmad F; Mandava S; Das BR
Cancer Invest; 2010 Jan; 28(1):63-73. PubMed ID: 19995225
[TBL] [Abstract][Full Text] [Related]
19. AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.
Pabst T; Mueller BU; Harakawa N; Schoch C; Haferlach T; Behre G; Hiddemann W; Zhang DE; Tenen DG
Nat Med; 2001 Apr; 7(4):444-51. PubMed ID: 11283671
[TBL] [Abstract][Full Text] [Related]
20. Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias.
Carbuccia N; Trouplin V; Gelsi-Boyer V; Murati A; Rocquain J; Adélaïde J; Olschwang S; Xerri L; Vey N; Chaffanet M; Birnbaum D; Mozziconacci MJ
Leukemia; 2010 Feb; 24(2):469-73. PubMed ID: 19865112
[No Abstract] [Full Text] [Related]
[Next] [New Search]